BBAGF (BB Biotech AG) Total Noninterest Expense: $26 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBAGF BB Biotech AG BBAGF
15 GF Score
Price $76.06
! 4 Warning Signs
View Full Analysis

What is BB Biotech AG Total Noninterest Expense?

BB Biotech AG BBAGF -29.53% 15 Total Noninterest Expense is $26 Mil as of Mar. 2026. GuruFocus rates BBAGF with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

BB Biotech AG's Total Noninterest Expense for the three months ended in Mar. 2026 was $5 Mil. BB Biotech AG's Total Noninterest Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $26 Mil.

BB Biotech AG Total Noninterest Expense Related Terms

BB Biotech AG Total Noninterest Expense Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Total Noninterest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Total Noninterest Expense Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Noninterest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.25 7.00 8.05 7.14 11.05

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Noninterest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.18 8.01 8.42 3.94 5.49
BBAGF
15GF Score
BB Biotech AG BBAGF
Total Noninterest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Total Noninterest Expense Calculation

Total Noninterest Expense is any expenses incurred that not related to interest. It includes:
Selling, General, & Admin. Expense
Occupancy
Equipment
Professional fees
Amortization of intangibles
Any other special income/charges (too numerous to list)
Some banks can do choose to report each of these items separately. Yet, there are a variety of noninterest expense which are simply too numerous to list.

Total Noninterest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Noninterest Expense of $26 Mil mean?
BB Biotech AG (BBAGF) has a Total Noninterest Expense of $26 Mil as of Mar. 2026. Total noninterest expense is any expenses incurred that not related to interest. View historical data on BB Biotech AG and its competitors.
Is BB Biotech AG's Total Noninterest Expense too high?
BB Biotech AG's current Total Noninterest Expense is $26 Mil. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Total Noninterest Expense compare to VRTX and REGN?
BB Biotech AG's Total Noninterest Expense of $26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Noninterest Expense for a Biotechnology company?
A good Total Noninterest Expense depends on the Biotechnology industry context. However, Total Noninterest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Noninterest Expense mean?
A high Total Noninterest Expense can signal that a stock is expensive relative to its fundamentals. Total noninterest expense is any expenses incurred that not related to interest. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current Total Noninterest Expense is $26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (BBAGF) has a current Total Noninterest Expense of $26 Mil. The current Total Noninterest Expense is $26 Mil. BB Biotech AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Noninterest Expense calculated?
Total Noninterest Expense is calculated from a company's financial statements. For BB Biotech AG (BBAGF), the current Total Noninterest Expense is $26 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for BBAGF

Total Noninterest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.06
Price